The update introduces features designed to assist clinicians in managing patients with pulmonary diseases like acute respiratory distress syndrome.
Dräger has received US Food and Drug Administration 510(k) clearance for its latest software update, Version 3.10, for the Evita V800 ventilator.
The software release provides additional features to help manage the mechanical ventilation of patients with pulmonary diseases, including acute respiratory distress syndrome, according to a press release from the company.
Included in the update is decelerating flow during volume control ventilation. This feature provides clinician-controlled flow intended to match patient demand while adhering to recommended safeguards for acute respiratory distress syndrome.
The software also includes guidance maps for positive end-expiratory pressure and fraction of inspired oxygen tables. These maps are designed to facilitate clinician decision-making when determining ventilator settings.
Furthermore, the update allows for the calculation of driving pressure and semi-automated static compliance. These features assist clinicians in the management of inspiratory settings, which can potentially reduce the risk of ventilator-induced lung injury, according to the release.
“Dräger continues to be on the forefront of technology, the addition of these new features for the Evita V800 is another example of Dräger’s commitment to research and development for respiratory care. Dräger is proud to again serve our customers with the latest technology,” says Lothar Thielen, president and CEO for Draeger, Inc, in a release.
